Antithrombotic management in catheter ablation for ventricular arrhythmias - Mini review.

IF 2.6 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Journal of cardiology Pub Date : 2025-08-21 DOI:10.1016/j.jjcc.2025.08.006

Kanae Hasegawa, William G Stevenson

引用次数: 0

Abstract

Radiofrequency catheter ablation (RFCA) is a common treatment option for ventricular arrhythmias (VA). Risks of RFA for VA include emboli and bleeding complications. In contrast to atrial fibrillation ablation procedures, for which anticoagulation therapy is relatively well standardized, peri-procedural antithrombotic therapy practices for RFCA of VA vary among laboratories and remains an area of investigation. This summary focuses on the current evidence-based antithrombotic therapies of RFCA for VA, with a particular emphasis on two recent major studies.

查看原文本刊更多论文

导管消融治疗室性心律失常的抗血栓管理。

射频导管消融（RFCA）是室性心律失常（VA）的常见治疗选择。RFA治疗VA的风险包括栓塞和出血并发症。房颤消融手术的抗凝治疗相对标准化，与之相反，室性心律失常RFCA的术中抗凝治疗实践在各个实验室中各不相同，仍然是一个研究领域。本综述重点介绍了目前以证据为基础的RFCA治疗VA的抗血栓疗法，并特别强调了最近的两项主要研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

4.90

自引率

8.00%

发文量

202

审稿时长

29 days

期刊介绍： The official journal of the Japanese College of Cardiology is an international, English language, peer-reviewed journal publishing the latest findings in cardiovascular medicine. Journal of Cardiology (JC) aims to publish the highest-quality material covering original basic and clinical research on all aspects of cardiovascular disease. Topics covered include ischemic heart disease, cardiomyopathy, valvular heart disease, vascular disease, hypertension, arrhythmia, congenital heart disease, pharmacological and non-pharmacological treatment, new diagnostic techniques, and cardiovascular imaging. JC also publishes a selection of review articles, clinical trials, short communications, and important messages and letters to the editor.